Agile Therapeutics (AGRX) Stock Chart & Stock Price History → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free AGRX Stock Alerts $0.41 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Agile Therapeutics Stock Price Performance5 Day Performance+2.45%1 Month Performance+44.24%3 Month Performance-68.10%6 Month Performance-79.37%Year-To-Date Performance-78.73%1 Year Performance-92.97% Receive AGRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. AGRX Stock Chart for Tuesday, May, 7, 2024 AGRX Chart by TradingView Agile Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$0.38$0.41+7.99%$0.41$0.3827,914 shs$2.85 million05/03/2024$0.40$0.38-5.14%$0.43$0.3838,847 shs$2.63 million05/02/2024$0.44$0.40-7.90%$0.45$0.4013,473 shs$2.78 million05/01/2024$0.45$0.44-1.24%$0.44$0.4031,757 shs$3.02 million04/30/2024$0.43$0.45+3.56%$0.49$0.4327,401 shs$3.05 million04/29/2024$0.40$0.43+7.43%$0.43$0.4072,489 shs$2.95 million Get the Latest News and Ratings for AGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$0.40$0.40$0.43$0.4028,123 shs$2.74 million04/25/2024$0.40$0.40-0.07%$0.42$0.3785,721 shs$2.74 million04/24/2024$0.37$0.40+8.22%$0.41$0.3673,534 shs$2.74 million04/23/2024$0.39$0.37-6.12%$0.40$0.3684,019 shs$2.54 million04/22/2024$0.38$0.39+3.68%$0.40$0.3715,937 shs$2.70 million04/19/2024$0.37$0.38+2.70%$0.40$0.3747,561 shs$2.61 million04/18/2024$0.37$0.37+0.60%$0.38$0.3715,137 shs$2.54 million04/17/2024$0.39$0.37-4.61%$0.41$0.36113,933 shs$2.52 million04/16/2024$0.37$0.39+4.10%$0.40$0.37123,040 shs$2.65 million04/15/2024$0.36$0.37+1.74%$0.40$0.3635,157 shs$2.54 million04/12/2024$0.42$0.36-13.36%$0.40$0.3678,790 shs$2.50 million04/11/2024$0.37$0.42+13.94%$0.42$0.32313,704 shs$2.88 million04/10/2024$0.39$0.37-6.40%$0.38$0.3596,194 shs$2.53 million04/09/2024$0.29$0.39+35.86%$0.40$0.35295,767 shs$2.70 million04/08/2024$0.29$0.29+0.87%$0.40$0.25184,513 shs$1.99 million04/05/2024$0.28$0.29+2.72%$0.31$0.2734,446 shs$851,000.0004/04/2024$0.27$0.28+2.68%$0.30$0.27127,186 shs$829,000.0004/03/2024$0.27$0.27+0.96%$0.29$0.26245,831 shs$807,000.0004/02/2024$0.27$0.27$0.29$0.26376,475 shs$799,000.0004/01/2024$0.34$0.27-20.59%$0.34$0.22376,475 shs$799,000.0003/29/2024$0.34$0.34$0.41$0.31293,428 shs$1.01 million03/28/2024$0.33$0.34+1.80%$0.41$0.31293,405 shs$1.01 million03/27/2024$0.33$0.33$0.42$0.321.71 million shs$989,000.0003/26/2024$0.60$0.33-44.54%$0.34$0.201.71 million shs$989,000.0003/25/2024$0.55$0.60+10.11%$0.61$0.522.13 million shs$1.79 million03/22/2024$0.56$0.55-2.51%$0.57$0.51422,836 shs$1.62 million03/21/2024$0.58$0.56-3.11%$0.58$0.55340,564 shs$1.66 million03/20/2024$0.53$0.58+9.74%$0.58$0.50470,535 shs$1.71 million03/19/2024$0.56$0.53-5.79%$0.67$0.51895,637 shs$1.56 million03/18/2024$0.54$0.56+3.13%$0.58$0.53350,923 shs$1.66 million03/15/2024$0.59$0.54-8.14%$0.59$0.51807,705 shs$1.61 million03/14/2024$0.71$0.59-16.27%$0.70$0.521.70 million shs$1.75 million03/13/2024$0.73$0.71-3.81%$0.83$0.7013.68 million shs$2.09 million03/12/2024$0.73$0.73+1.24%$0.74$0.70223,928 shs$2.17 million[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond03/11/2024$0.75$0.73-2.68%$0.75$0.70105,640 shs$2.15 million03/08/2024$0.76$0.75-2.10%$0.78$0.71160,132 shs$2.21 million03/07/2024$0.81$0.76-5.62%$0.82$0.75207,164 shs$2.25 million03/06/2024$0.82$0.81-1.67%$0.84$0.77139,703 shs$2.39 million03/05/2024$0.84$0.82-2.92%$0.87$0.8175,335 shs$2.43 million03/04/2024$0.85$0.84-0.62%$0.88$0.83153,494 shs$2.50 million03/01/2024$0.80$0.85+6.92%$0.85$0.80234,239 shs$2.52 million02/29/2024$0.77$0.80+3.45%$0.81$0.78118,786 shs$2.35 million02/28/2024$0.79$0.77-2.80%$0.81$0.77260,096 shs$2.28 million02/27/2024$0.81$0.79-2.18%$0.83$0.78216,833 shs$2.34 million02/26/2024$0.89$0.81-9.19%$0.85$0.78459,451 shs$2.40 million02/23/2024$0.95$0.89-6.06%$0.93$0.78871,498 shs$2.63 million02/22/2024$0.99$0.95-4.52%$1.31$0.9314.79 million shs$2.80 million02/21/2024$1.05$0.99-5.50%$1.05$0.95104,852 shs$2.94 million02/20/2024$1.20$1.05-12.50%$1.22$1.00248,322 shs$3.11 million02/19/2024$1.20$1.20$1.27$1.1995,800 shs$3.55 million02/16/2024$1.22$1.20-1.83%$1.27$1.1995,516 shs$3.56 million02/15/2024$1.20$1.22+1.87%$1.24$1.1842,165 shs$3.62 million02/14/2024$1.20$1.20$1.21$1.1929,504 shs$3.55 million02/13/2024$1.19$1.20+0.84%$1.20$1.1845,844 shs$3.55 million02/12/2024$1.17$1.19+1.70%$1.22$1.1782,239 shs$3.52 million02/09/2024$1.20$1.17-2.49%$1.26$1.1762,481 shs$3.46 million02/08/2024$1.30$1.20-7.69%$1.29$1.15176,025 shs$3.55 million02/07/2024$1.51$1.30-13.91%$1.52$1.25163,050 shs$3.26 million02/06/2024$1.43$1.51+5.59%$1.52$1.4317,230 shs$3.79 million Related Companies: Avenue Therapeutics Stock Chart Aravive Stock Chart Virpax Pharmaceuticals Stock Chart Biophytis Stock Chart NovaBay Pharmaceuticals Stock Chart Phio Pharmaceuticals Stock Chart Biophytis Stock Chart Aridis Pharmaceuticals Stock Chart GeoVax Labs Stock Chart Cyclacel Pharmaceuticals Stock Chart Receive AGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Agile Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AGRX) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBiden replacement revealed?Paradigm PressThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agile Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.